Ann Lin

Ann Lin is the co-founder and CEO of Cromatic, an AI-native RevOps platform that helps life-science companies find and manage contract research organizations (CROs). A Stanford genetics PhD and Forbes 30 Under 30 (Science, 2020) honoree, she made her name in the lab of Jason Sheltzer at Cold Spring Harbor, where her team showed that a celebrated cancer drug did not hit its supposed target. After scientifically co-founding the drug-discovery startup Meliora Therapeutics, she turned a Google Sheet of outsourcing complaints into a company, raising a $5.3M seed round in 2023 to fix the notoriously opaque market for biotech R&D vendors.